Jefferies Financial Group Inc. Sells 20,209 Shares of The Cooper Companies, Inc. $COO

Key Points

• Jefferies Financial Group cut its stake in Cooper Companies by 48.3%, selling 20,209 shares in the quarter and leaving 21,600 shares worth about $1.48 million according to its latest 13F filing.
• Cooper beat Q1 EPS estimates ($1.10 vs. $1.03) with revenue up 6.2% year-over-year, set Q2 2026 EPS guidance of 4.580–4.660, and holds a consensus analyst rating of Moderate Buy with an average price target of $90.79.

Jefferies Financial Group Inc. lessened its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 48.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 21,600 shares of the medical device company's stock after selling 20,209 shares during the period. Jefferies Financial Group Inc.'s holdings in Cooper Companies were worth $1,481,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of COO. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Cooper Companies by 48.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company's stock worth $1,890,000 after buying an additional 7,363 shares during the period. Assetmark Inc. raised its holdings in Cooper Companies by 357.8% in the 2nd quarter. Assetmark Inc. now owns 618 shares of the medical device company's stock worth $44,000 after acquiring an additional 483 shares during the period. Fox Run Management L.L.C. bought a new position in Cooper Companies in the 2nd quarter worth $514,000. Aviva PLC lifted its position in Cooper Companies by 6.9% during the 2nd quarter. Aviva PLC now owns 148,728 shares of the medical device company's stock worth $10,583,000 after acquiring an additional 9,576 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in Cooper Companies by 11.1% during the 2nd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 383,736 shares of the medical device company's stock worth $27,307,000 after acquiring an additional 38,427 shares during the last quarter. Institutional investors own 24.39% of the company's stock.

Cooper Companies Trading Down 0.9%

Shares of COO stock opened at $73.75 on Thursday. The firm has a fifty day moving average of $81.66 and a 200-day moving average of $76.00. The stock has a market cap of $14.39 billion, a price-to-earnings ratio of 36.51, a P/E/G ratio of 1.92 and a beta of 1.02. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $89.83. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.03 by $0.07. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same period in the previous year, the business earned $0.92 EPS. The firm's revenue was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Insider Activity at Cooper Companies

In related news, Director Lawrence Erik Kurzius bought 2,000 shares of the company's stock in a transaction dated Wednesday, December 17th. The stock was acquired at an average cost of $82.50 per share, with a total value of $165,000.00. Following the acquisition, the director owned 7,777 shares in the company, valued at approximately $641,602.50. This represents a 34.62% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Maria Rivas bought 1,000 shares of the business's stock in a transaction that occurred on Thursday, December 18th. The shares were bought at an average price of $82.13 per share, with a total value of $82,130.00. Following the transaction, the director directly owned 11,141 shares in the company, valued at $915,010.33. This trade represents a 9.86% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders acquired 16,014 shares of company stock valued at $1,304,416. Corporate insiders own 2.08% of the company's stock.

Analyst Ratings Changes

COO has been the topic of several research analyst reports. Rothschild & Co Redburn downgraded Cooper Companies from a "buy" rating to a "neutral" rating and set a $85.00 price target on the stock. in a research report on Wednesday, March 4th. Piper Sandler reissued an "overweight" rating and set a $94.00 price objective (up from $83.00) on shares of Cooper Companies in a research report on Friday, December 5th. Wells Fargo & Company increased their target price on Cooper Companies from $72.00 to $82.00 and gave the company an "equal weight" rating in a research note on Friday, December 5th. Stifel Nicolaus set a $95.00 target price on Cooper Companies and gave the company a "buy" rating in a report on Friday, December 5th. Finally, Robert W. Baird lifted their price target on Cooper Companies from $85.00 to $98.00 and gave the stock an "outperform" rating in a research report on Friday, December 5th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $90.79.

Cooper Companies Profile

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.